Shares of Concord Medical Services Hldg Ltd (NYSE:CCM) have earned a consensus broker rating score of 3.70 (Sell) from the one analysts that provide coverage for the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a sell rating.
Analysts have set a one year consensus price target of $3.00 for the company, according to Zacks. Zacks has also given Concord Medical Services an industry rank of 91 out of 255 based on the ratings given to related companies.
CCM traded up $0.35 during trading hours on Friday, hitting $2.70. 4,349 shares of the company’s stock were exchanged, compared to its average volume of 4,720. Concord Medical Services has a 1-year low of $2.35 and a 1-year high of $4.20. The stock has a market capitalization of $117.08 million, a price-to-earnings ratio of -2.65 and a beta of 0.12.
A hedge fund recently raised its stake in Concord Medical Services stock. Wedbush Securities Inc. grew its holdings in shares of Concord Medical Services Hldg Ltd (NYSE:CCM) by 28.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 21,432 shares of the company’s stock after buying an additional 4,757 shares during the period. Wedbush Securities Inc.’s holdings in Concord Medical Services were worth $60,000 as of its most recent filing with the Securities and Exchange Commission. 1.76% of the stock is currently owned by institutional investors.
About Concord Medical Services
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy systems, and diagnostic imaging services.
Featured Story: Key terms to understand channel trading
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.